Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viens

Showing results (171-180 of 244) with videos related to

Pageof 25
Sort By:
European Cytokine Network|March 1, 1991
Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patientsD Blaise, P Viens, D Olive, et al.
European Cytokine Network|August 1, 1991
Interleukin-2 induces chemotactic deficiency in patients with onco hematologic malignancies and autologous bone marrow transplantationA M Stoppa, C Fossat, D Blaise, et al.
L'Union Medicale Du Canada|October 1, 1981
[Parasitic uveitis in Quebec]P Viens, J Milot, J L Jacob, et al.
Anticancer Research|June 9, 2001
Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokineticsA Goncalves, J Camerlo, H Bun, et al.
Anticancer Research|June 12, 1999
High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institutionF Bertucci, P Viens, G Gravis, et al.
Bulletin Du Cancer|April 21, 2001
[Molecular typing of breast cancer: transcriptomics and DNA microarrays]F Bertucci, R Houlgatte, C Nguyen, et al.
Human Molecular Genetics|December 15, 2000
Gene expression profiling of primary breast carcinomas using arrays of candidate genesF Bertucci, R Houlgatte, A Benziane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)J A Ledermann, R Herd, D Maraninchi, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Bone Marrow Transplantation|February 10, 2004
Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimenM Mohty, A M Mohty, D Blaise, et al.
Pageof 25

Showing results (171-180 of 244) with videos related to

Sort By:
Pageof 25
European Cytokine Network|March 1, 1991
Recombinant interleukin-2 (rIL-2) after autologous bone marrow transplantation (BMT): a pilot study in 19 patientsD Blaise, P Viens, D Olive, et al.
European Cytokine Network|August 1, 1991
Interleukin-2 induces chemotactic deficiency in patients with onco hematologic malignancies and autologous bone marrow transplantationA M Stoppa, C Fossat, D Blaise, et al.
L'Union Medicale Du Canada|October 1, 1981
[Parasitic uveitis in Quebec]P Viens, J Milot, J L Jacob, et al.
Anticancer Research|June 9, 2001
Phase II study of a combination of cisplatin, all-trans-retinoic acid and interferon-alpha in squamous cell carcinoma: clinical results and pharmacokineticsA Goncalves, J Camerlo, H Bun, et al.
Anticancer Research|June 12, 1999
High-dose chemotherapy with hematopoietic stem cell support in patients with advanced epithelial ovarian cancer: analysis of 67 patients treated in a single institutionF Bertucci, P Viens, G Gravis, et al.
Bulletin Du Cancer|April 21, 2001
[Molecular typing of breast cancer: transcriptomics and DNA microarrays]F Bertucci, R Houlgatte, C Nguyen, et al.
Human Molecular Genetics|December 15, 2000
Gene expression profiling of primary breast carcinomas using arrays of candidate genesF Bertucci, R Houlgatte, A Benziane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
High-dose chemotherapy for ovarian carcinoma: long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)J A Ledermann, R Herd, D Maraninchi, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Bone Marrow Transplantation|February 10, 2004
Cytomegalovirus-specific immune recovery following allogeneic HLA-identical sibling transplantation with reduced-intensity preparative regimenM Mohty, A M Mohty, D Blaise, et al.
Pageof 25